Sular Extended-Release Tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sular Extended-Release Tablets, covering 2009-09-18 to 2009-09-18. Get the full timeline:
Most recent: Clinical Trial Update: Single-Dose Fed Bioequivalence Study of Nisoldipine Extended-Release Tablets (40 mg; Mylan) and Sular® Extended-Release Tablets (40 mg; First Horizon) in Healthy Volunteers [Phase 1]